Novartis
Novartis buys out cancer specialist AAA in $3.9 bn deal
01 Nov 2017
The move would give Novartis a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Apple founder Steve Jobs
The move would give Novartis a platform in radiopharmaceuticals and access to a new therapy for the kind of cancer that killed Apple founder Steve Jobs